The American Academy of Physical Medicine and Rehabilitation (AAPM&R) has issued new consensus guidance on the assessment and treatment of neurologic sequelae in patients with long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC). The new recommendations, which were published online May 16 in Physical Medicine & Rehabilitation, […]
Read More
Neurologic adverse events after COVID-19 vaccination were rare, an analysis of Vaccine Adverse Event Reporting System (VAERS) data showed. Of nearly 307 million COVID vaccine doses administered in the U.S. in the first half of 2021, 314,610 (0.1%) people reported any adverse event and 105,214 (0.03%) reported neurologic adverse events, […]
Read More
About half of children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) have new-onset neurologic symptoms, research shows. These symptoms involve the central and peripheral nervous systems but do not always affect the respiratory system. In addition, neurologic symptoms appear to be more common in severe presentations of […]
Read More
Cognitive dysfunction tops the list of neurologic complaints in long-haul COVID-19 patients whose illness wasn’t severe enough for them to be hospitalized, but it isn’t the only problem, new research shows. Researchers who tracked 100 COVID-19 long-haul, nonhospitalized patients from May to November found 85% reported four or more neurologic […]
Read More